This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

METabolic EXplorer Past Earnings Performance

Past criteria checks 0/6

METabolic EXplorer's earnings have been declining at an average annual rate of -239.2%, while the Chemicals industry saw earnings growing at 13.6% annually. Revenues have been declining at an average rate of 36.4% per year.

Key information

-239.2%

Earnings growth rate

-166.5%

EPS growth rate

Chemicals Industry Growth12.4%
Revenue growth rate-36.4%
Return on equity-51.9%
Net Margin-29.3%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How METabolic EXplorer makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:7ME Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23168-49309
31 Mar 23198-50329
31 Dec 22228-513310
30 Sep 22246-333310
30 Jun 22264-153310
31 Mar 2221834299
31 Dec 2117283248
30 Sep 2110579177
30 Jun 21387596
31 Mar 21203376
31 Dec 202-946
30 Sep 202-956
30 Jun 202-856
31 Mar 202-856
31 Dec 192-855
30 Sep 193-955
30 Jun 193-955
31 Mar 194-855
31 Dec 186-655
30 Sep 186-956
30 Jun 187-1156
31 Mar 187-1146
31 Dec 177-1146
30 Sep 176-146
30 Jun 176846
31 Mar 175747
31 Dec 164747
30 Sep 164047
30 Jun 164-747
31 Mar 163-747
31 Dec 153-746
30 Sep 154-746
30 Jun 154-645
31 Mar 155-545
31 Dec 146-445
30 Sep 144-344
30 Jun 143-243
31 Mar 142-342
31 Dec 131-441
30 Sep 131-741

Quality Earnings: 7ME is currently unprofitable.

Growing Profit Margin: 7ME is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 7ME's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare 7ME's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 7ME is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-1%).


Return on Equity

High ROE: 7ME has a negative Return on Equity (-51.87%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/03 16:56
End of Day Share Price 2024/05/06 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

METabolic EXplorer S.A. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charles-Louis PlanadeArkeon Finance
Arsene GuekamCIC Market Solutions (ESN)
Charles BordesKepler Cheuvreux